PhD Scientist with 10+ years of hands-on research proficiency in the fields of small molecule drug discovery and preclinical biomarkers, conducting in vivo and in vitro translational studies in the field of cancer biology, with specific focus on hematology, blood malignancies, and therapeutics. <br> I have successfully authored several grant proposals (NJ Department of Health, American Society of Hematology, WES leukemia society), top-notch scientific papers (7 peer-reviewed scientific articles and counting), technical reports (international patent deposit for anti-leukemic small inhibitors), and presented my results to world-renowned experts during national and international meetings (Outstanding Abstract Award - Federation of American Societies for Experimental Biology among the others). In a nutshell:  Oncology scientist with proficiency in drug discovery, pre-clinical discovery, target validation, epigenetics.  Expert in in vivo/in vitro disease and mechanistic modeling, with focus on T-cell and myeloid leukemias therapeutics.  In vivo modeling of tumor generation, bone marrow transplants, PDXs, in vivo treatment, tissue sampling, necroscopy.  Gene editing expertise via viral and RNP gene transduction, RNAi, gene overexpression, gene silencing, CRISPR/Cas9.  Expertness in cell-based techniques, primary human samples isolation, cell culturing, aseptic techniques, drug testing.  NGS assays (RNA-Seq, scRNA-Seq, ChIP-Seq), RNA assays (qPCR), DNA assays (PCR, ChIP), Protein assays (IP, WB), Flow cytometry.  Critical thinker capable in managing complex scientific programs with excellent track record of scientific achievements.